HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells

International Journal of Oncology

Volumn 44, Issue 2, 2014, Pages 393-402

  Guan, Zhenfeng ^a   Ding, Chen ^a   Du, Yiqing ^a   Zhang, Kai ^a   Zhu, Jian Ning ^a   Zhang, Tingting ^a   He, Dalin ^b   Xu, Shan ^a   Wang, Xinyang ^a   Fan, Jinhai ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bladder cancer; Epithelial to mesenchymal transition; Hypoxia; Hypoxia induced factor; Hypoxia associated factor; Invasion; Migration; NF B

Indexed keywords

ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL ADHESION; CELL HYPOXIA; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; WOUND HEALING;

EID: 84894412911     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2210     Document Type: Article

References (44)

1. Nathke I and Rocha S: Antagonistic crosstalk between APC and HIF-1alpha. Cell Cycle 10: 1545-1547, 2011.
2. Yoo YG, Christensen J, Gu J and Huang LE: HIF-1alpha mediates tumor hypoxia to confer a perpetual mesenchymal phenotype for malignant progression. Sci Signal 4: pt4, 2011.
3. Haase VH: Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 291: F271-F281, 2006.
4. Henze AT and Acker T: Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle 9: 2749-2763, 2010.
5. Berra E, Ginouves A and Pouyssegur J: The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep 7: 41-45, 2006.
6. Koh MY and Powis G: Passing the baton: the HIF switch. Trends Biochem Sci 37: 364-372, 2012.
7. Yoo YG, Christensen J and Huang LE: HIF-1alpha confers aggressive malignant traits on human tumor cells independent of its canonical transcriptional function. Cancer Res 71: 1244-1252, 2011.
8. Loboda A, Jozkowicz A and Dulak J: HIF-1 and HIF-2 transcription factors - similar but not identical. Mol Cells 29: 435-442, 2010.
9. Majmundar AJ, Wong WJ and Simon MC: Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40: 294-309, 2010.
10. Rohwer N and Cramer T: Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat 14: 191-201, 2011.
11. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB and Rich JN: Hypoxia inducible factors in cancer stem cells. Br J Cancer 102: 789-795, 2010.
12. Tafani M, Schito L, Pellegrini L, et al: Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis 32: 1167-1175, 2011.
13. Yamakuchi M, Yagi S, Ito T and Lowenstein CJ: MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS One 6: e20291, 2011.
14. Zhdanov AV, Dmitriev RI, Golubeva AV, Gavrilova SA and Papkovsky DB: Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells. Biochim Biophys Acta 1830: 3553-3569, 2013.
15. Petrella BL, Lohi J and Brinckerhoff CE: Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene 24: 1043-1052, 2005. (Pubitemid 40313881)
16. Koh MY, Lemos RJ, Liu X and Powis G: The hypoxia-associated factor switches cells from HIF-1alpha- to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res 71: 4015-4027, 2011.
17. Li Z and Rich JN: Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol 345: 21-30, 2010.
18. Yeung TM, Gandhi SC and Bodmer WF: Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci USA 108: 4382-4387, 2011.
19. Yeramian A, Santacana M, Sorolla A, et al: Nuclear factor-kappaB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1alpha independent manner. Lab Invest 91: 859-871, 2011.
20. Xue Y, Li NL, Yang JY, Chen Y, Yang LL and Liu WC: Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression. Am J Physiol Heart Circ Physiol 300: H2169-H2176, 2011.
21. Nys K, Maes H, Dudek AM and Agostinis P: Uncovering the role of hypoxia inducible factor-1alpha in skin carcinogenesis. Biochim Biophys Acta 1816: 1-12, 2011.
22. Ghosh G, Wang VY, Huang DB and Fusco A: NF-kappaB regulation: lessons from structures. Immunol Rev 246: 36-58, 2012.
23. van Uden P, Kenneth NS, Webster R, Muller HA, Mudie S and Rocha S: Evolutionary conserved regulation of HIF-1beta by NF-kappaB. PLoS Genet 7: e1001285, 2011.
24. Sun SC: The noncanonical NF-kappaB pathway. Immunol Rev 246: 125-140, 2012.
25. Paliwal P, Arora D and Mishra AK: Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale. Indian J Pathol Microbiol 55: 443-449, 2012.
26. Jing Y, Han Z, Zhang S, Liu Y and Wei L: Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci 1: 29, 2011.
27. Wu ST, Sun GH, Hsu CY, et al: Tumor necrosis factor-alpha induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism. Exp Biol Med 236: 1022-1029, 2011.
28. Harhaj EW and Dixit VM: Regulation of NF-kappaB by deubiquitinases. Immunol Rev 246: 107-124, 2012.
29. Gilmore TD and Wolenski FS: NF-kappaB: where did it come from and why? Immunol Rev 246: 14-35, 2012.
30. Kanarek N and Ben-Neriah Y: Regulation of NF-kappaB by ubiquitination and degradation of the IkappaBs. Immunol Rev 246: 77-94, 2012.
31. Brennan P and O'Neill LA: 2-mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrollidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF kappa B by PDTC. Biochem J 320: 975-981, 1996.
32. Hayakawa M, Miyashita H, Sakamoto I, et al: Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22: 3356-3366, 2003. (Pubitemid 36834865)
33. Julien S, Puig I, Caretti E, et al: Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7456, 2007. (Pubitemid 350158710)
34. Vaupel P and Mayer A: Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26: 225-239, 2007. (Pubitemid 47101660)
35. Weidemann A and Johnson RS: Biology of HIF-1alpha. Cell Death Differ 15: 621-627, 2008.
36. Saito T and Kawaguchi H: HIF-2alpha as a possible therapeutic target of osteoarthritis. Osteoarthritis Cartilage 18: 1552-1556, 2010.
37. Uchida T, Rossignol F, Matthay MA, et al: Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J Biol Chem 279: 14871-14878, 2004.
38. Myllyharju J and Schipani E: Extracellular matrix genes as hypoxia-inducible targets. Cell Tissue Res 339: 19-29, 2010.
39. Jiang H, Zhu Y, Xu H, Sun Y and Li Q: Activation of hypoxia-inducible factor-1alpha via nuclear factor-kappa B in rats with chronic obstructive pulmonary disease. Acta Biochim Biophys Sin 42: 483-488, 2010.
40. Levidou G, Saetta AA, Korkolopoulou P, et al: Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder. Virchows Arch 452: 295-304, 2008.
41. Gorlach A and Bonello S: The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem J 412: e17-e19, 2008.
42. Taylor CT and Cummins EP: The role of NF-kappaB in hypoxia-induced gene expression. Ann NY Acad Sci 1177: 178-184, 2009.
43. van Uden P, Kenneth NS and Rocha S: Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 412: 477-484, 2008.
44. Nam SY, Ko YS, Jung J, et al: A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-kappaB promotes gastric tumour growth and angiogenesis. Br J Cancer 104: 166-174, 2011.